The stem cell therapy and its emerging markets

<p>Deven Patel</p>

The stem cell therapy and its emerging markets

Deven Patel

Global Institute of Sten Cell Therapy and Research, USA

: J Diagnos Tech Biomed Anal

Abstract

The field of stem cell research has come a long way from the early days of bone marrow transplant and progressed into sophisticated domain of autologous, allogeneic and embryonic stem cell and has largely escaped the risks that were faced during the emergence of genetic engineering. In fact it has reached critical mass with a number of companies are carrying out cutting edge research and a number of government who are recognizing the significant impact it would have in the well being of humanity with the promise of significant reduction of healthcare costs. We are already seeing evidence of positive impact on patients suffering from Diabetes, Liver Disease, Lung Disease, Autism, Alzheimer’s, MS, and Cerebral Palsy. And its only going to get better once the brilliant research meets the motivation of government and capital markets to bring this epoch making technology to market and help cure degenerative diseases for the first time in human history.